What is Veracyte's deferred revenue?

Veracyte (VCYT) reported deferred revenue of $749K in Q1 2026.

How has Veracyte's deferred revenue changed year-over-year?

Veracyte's deferred revenue decreased by 56.3% year-over-year, from $1.71M to $749K.

What is the long-term trend for Veracyte's deferred revenue?

Over 5 years (2020 to 2025), Veracyte's deferred revenue has grown at a 25.6% compound annual growth rate (CAGR), from $371K to $1.16M.

What does deferred revenue mean?

Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.

Veracyte VCYT Deferred Revenue

Deferred Revenue at other companies

Guardant HealthGH

$47.77M+31.6%

Natera, Inc.NTRA

$36.85M+79.3%

Labcorp HoldingsLH

$405.2M+4.4%

Agilent TechnologiesA

$433M+0.9%

Bio-Rad LaboratoriesBIO

——

RevvityRVTY

——

Other financials

Income statement

See full

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

See full

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

See full

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

See full

Market cap$4.29B+10.7%

Profitability

See full

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

See full

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veracyte's deferred revenue?: Veracyte (VCYT) reported deferred revenue of $749K in Q1 2026.
How has Veracyte's deferred revenue changed year-over-year?: Veracyte's deferred revenue decreased by 56.3% year-over-year, from $1.71M to $749K.
What is the long-term trend for Veracyte's deferred revenue?: Over 5 years (2020 to 2025), Veracyte's deferred revenue has grown at a 25.6% compound annual growth rate (CAGR), from $371K to $1.16M.
What does deferred revenue mean?: Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.